Product Reports Resources Pricing Login Book a demo

ATAI Life Sciences

Biotech & Life Sciences · Berlin, Germany · Founded 2018 · IPO 2021

A biotechnology company pioneering mental health innovation

Valuation $2.43B
Revenue $4.1M
Power Law Unicorn$1–10B valuation tier
Knowledge graph
News Eli Lilly to acquire AtaiBeckley for $2.8B to target treatment-resistant depression Jul 16, 2026 Market map Psychedelic therapeutics

Talent graph

ATAI Life Sciences's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

21 investors on ATAI Life Sciences's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 2 investors entered at this stage
Apeiron Investment Group
HCS
Series A 3 investors entered at this stage
Thor Bjorgolfsson
Mike Novogratz
Peter Thiel
Series B+ 16 investors entered at this stage
What If Ventures
Fearless Ventures
Woodline Partners
Maryanna Saenko
Efrem Kamen
Highline Capital Management
Catalio Capital Management
Alpha Wave Global
Pura Vida Investments
Thiel Capital
Steve Jurvetson
Future Ventures
Neo Kuma Ventures
Christian Angermayer
Subversive Capital
Galaxy Investment Partners (Galaxy Digital)

ATAI Life Sciences mafia

Startups founded by ATAI Life Sciences alumni

Former ATAI Life Sciences employees who went on to start their own companies. Sorted by Dealroom signal score.

HeadingEst. 2020
ASAli SheikhUnited States
Signal score79
Centenara LabsEst. 2019
Christian AngermayerSwitzerland
Signal score64
ThirdwebEst. 2021
Steven BartlettUnited States
Signal score61
Kanna HealthEst. 2021
Lars Christian WildeUnited Kingdom
Signal score57

Book a demo to explore the full alumni network →

Global footprint

Where ATAI Life Sciences has talent and traffic

Workforce by country
🇩🇪 Germany · Berlin HQ
Book a demo for the full country breakdown
Web traffic by country
30K monthly visits
across markets
🇲🇽 Mexico22%
🇵🇪 Peru21.3%
🇺🇸 United States19.3%
🇩🇪 Germany11.7%
🇨🇦 Canada9.3%
Top 5 markets shown

Patent intelligence

$12M patent portfolio · 77 active families

Estimated portfolio value
$12M
0.49% of market cap · 19.8× larger than top peer Tubulis ($606k)
77 active patent families
Where ATAI Life Sciences innovates DimethyltryptamineDiseaseMedicinal chemistryPharmaceutical SubstancesPharmaceutical drug

Where ATAI Life Sciences concentrates vs peers

Each axis is a top-10 topic across ATAI Life Sciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

ATAI Life Sciences's 9 investments and acquisitions.

Every disclosed deal where ATAI Life Sciences appeared as a backer or acquirer, 2020–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

9 deals across ATAI Life Sciences's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where ATAI Life Sciences deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        ATAI Life Sciences's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        9 of 9 deals

        Market sentiment

        What the market is saying about ATAI Life Sciences

        An AI-synthesized read of the highest-engagement posts about ATAI Life Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See ATAI Life Sciences on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles